PTCT
PTC Therapeutics, Inc. · Healthcare
EVP and CLO Mark Elliott Boulding sold $157K of PTC Therapeutics, Inc.
Sold$157,293
$69.45Price
2,265Shares
−2%Stake
What PTCT did after the filing
- The stock from Thu, Apr 9 open, $71.02
- −1.7%
- S&P 500, same days
- +10.1%
Measured over 30 trading days, to the May 21 close.
Traded Mon, Apr 6. Filed Wed, Apr 8, 5:20 PM ET, after the close. Returns use the Apr 9 open and the May 21 close. Not investment advice.